Semler Scientific, Inc. (SMLR) shares plummeted by 5.97% in Friday's pre-market trading session, significantly underperforming the broader market. The steep decline in the healthcare technology firm's stock was primarily attributed to the company's announcement of a $75 million private offering of convertible senior notes, which raised concerns about potential equity dilution.
The company disclosed its intention to offer the convertible notes due 2030 to institutional buyers, with an option to purchase up to an additional $15 million worth of notes. While the final terms are yet to be determined, Semler Scientific stated that it intends to use a portion of the proceeds to fund capped call transactions and for the acquisition of bitcoin, in line with its bitcoin treasury strategy.
Additionally, the company released preliminary fourth-quarter results, showing revenue expectations in the range of $12.1 million to $12.5 million. Although reflecting year-over-year growth, the revenue guidance may have fallen short of some analysts' projections, further exacerbating the negative sentiment surrounding the stock.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。